Cassava sciences announces virtual presentation at the ad/pd™ 2024 international conference

Austin, texas, march 04, 2024 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, today announced plans to present a virtual oral presentation at the international conference on alzheimer's and parkison's disease (ad/pd 2024) taking place in lisbon, portugal from march 5-9, 2024.
SAVA Ratings Summary
SAVA Quant Ranking